Bernardo-Castro Sara, Donato Helena, Ferreira Lino, Sargento-Freitas João
Stroke Unit, Centro Hospitalar e Universitário de Coimbra EPE, Coimbra, Portugal.
Documentation Service, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal.
BMJ Open. 2020 Sep 18;10(9):e039280. doi: 10.1136/bmjopen-2020-039280.
Ischaemic stroke is the most prevalent type of stroke and is characterised by a myriad of pathological events triggered by a vascular arterial occlusion. Disruption of the blood-brain barrier (BBB) is a key pathological event that may lead to fatal outcomes. However, it seems to follow a multiphasic pattern that has been associated with distinct biological substrates and possibly contrasting outcomes. Addressing the BBB permeability (BBBP) along the different phases of stroke through imaging techniques could lead to a better understanding of the disease, improved patient selection for specific treatments and development of new therapeutic modalities and delivery methods. This systematic review will aim to comprehensively summarise the existing evidence regarding the evolution of the BBBP values during the different phases of an acute ischaemic stroke and correlate this event with the clinical outcome of the patient.
We will conduct a computerised search on Medline, EMBASE, Cochrane Central Register of Controlled Trials, Scopus and Web of Science. In addition, grey literature and ClinicalTrials.gov will be scanned. We will include randomised controlled trials, cohort, cross-sectional and case-controlled studies on humans that quantitatively assess the BBBP in stroke. Retrieved studies will be independently reviewed by two authors and any discrepancies will be resolved by consensus or with a third reviewer. Reviewers will extract the data and assess the risk of bias of the selected studies. If possible, data will be combined in a quantitative meta-analysis following the guidelines provided by Cochrane Handbook for Systematic Reviews of Interventions. We will assess cumulative evidence using the Grading of Recommendations, Assessment, Development and Evaluation approach.
Ethical approval is not needed. All data used for this work are publicly available. The result obtained from this work will be published in a peer-reviewed journal and disseminated in relevant conferences.
CRD42019147314.
缺血性中风是最常见的中风类型,其特征是由血管动脉闭塞引发的一系列病理事件。血脑屏障(BBB)的破坏是一个关键的病理事件,可能导致致命后果。然而,它似乎呈现出多相模式,这与不同的生物学底物以及可能截然不同的结果相关。通过成像技术在中风的不同阶段解决血脑屏障通透性(BBBP)问题,可能有助于更好地理解该疾病,改善特定治疗的患者选择,并开发新的治疗方式和给药方法。本系统评价旨在全面总结关于急性缺血性中风不同阶段BBBP值演变的现有证据,并将这一事件与患者的临床结局相关联。
我们将在Medline、EMBASE、Cochrane对照试验中央注册库、Scopus和科学网进行计算机检索。此外,还将检索灰色文献和ClinicalTrials.gov。我们将纳入对人类进行的随机对照试验、队列研究、横断面研究和病例对照研究,这些研究需定量评估中风中的BBBP。检索到的研究将由两位作者独立评审,任何分歧将通过共识解决或由第三位评审员裁定。评审员将提取数据并评估所选研究的偏倚风险。如果可能,将按照《Cochrane系统评价干预措施手册》提供的指南进行定量荟萃分析。我们将使用推荐分级、评估、制定和评价方法评估累积证据。
无需伦理批准。本研究使用的所有数据均为公开可用。本研究获得的结果将发表在同行评审期刊上,并在相关会议上传播。
PROSPERO注册号:CRD42019147314。